e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Pulmonary arterial hypertension diagnosis and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hemodynamics in highlanders with high altitude pulmonary hypertension in 1 year after finishing of sildenafil treatment
A. A. Aldashev, B. K. Kojonazarov, M. M. Mirrakhimov, N. W. Morrell, M. R. Wilkins (Bishkek, Kyrgyzstan; London, United Kingdom)
Source:
Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Session:
Pulmonary arterial hypertension diagnosis and therapy
Session type:
Oral Presentation
Number:
1338
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Aldashev, B. K. Kojonazarov, M. M. Mirrakhimov, N. W. Morrell, M. R. Wilkins (Bishkek, Kyrgyzstan; London, United Kingdom). Pulmonary hemodynamics in highlanders with high altitude pulmonary hypertension in 1 year after finishing of sildenafil treatment. Eur Respir J 2005; 26: Suppl. 49, 1338
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Haemodynamic evaluation of pulmonary hypertension
Source: Eur Respir J 2002; 20: 1314-1331
Year: 2002
Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Right and left ventricular function in lowlanders with COPD travelling to moderate altitude
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Clinical significance of right ventricular diastolic dysfunction in pulmonary arterial hypertension
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Right ventricular diastolic function in high altitude pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002
Cardiac function during exercise in pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005
High-altitude disease
Source: Respipedia Article
Year: 2017
The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012
Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 224-232
Year: 2013
Haemodynamic responses to exercise in patients with COPD
Source: Eur Respir J 2013; 41: 1031-1041
Year: 2013
The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
Deleterious effects of ß-blockers on exercise capacity and hemodynamics in portopulmonary hypertension
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 393-398
Year: 2008
Haemodynamics during vasodilator test comparing urapidil and nicardipine to NO in pulmonary arterial hypertension
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept